Page last updated: 2024-08-26

nimbolide and Neoplasms

nimbolide has been researched along with Neoplasms in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	2 (40.00)	2.80

Authors

Authors	Studies
Deng, H; Hao, J; Kim, C; Li, P; Liu, Z; Qin, T; Wang, XD; Yu, Y; Zhen, Y; Zhou, M	1
Mishra, R; Nagini, S; Nivetha, R; Palrasu, M	1
Barua, CC; Bodduluru, LN; Kasala, ER; Sistla, R; Thota, N	1
Goh, BC; Ho, PC; Lee, SC; Ong, PS; Phan, DD; Sethi, G; Soo, R; Thuya, WL; Wang, L; Wong, AL; Yong, WP; Zhang, J	1
Aggarwal, BB; Chaturvedi, MM; Gupta, SC; Hema, PS; Kannappan, R; Nair, M; Prasad, S; Ravindran, J; Reuter, S; Yadav, VR	1

Reviews

3 review(s) available for nimbolide and Neoplasms

Article	Year
Nimbolide, a Neem Limonoid, Is a Promising Candidate for the Anticancer Drug Arsenal. Journal of medicinal chemistry, 2021, 04-08, Volume: 64, Issue:7 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Limonins; Neoplasms; Signal Transduction	2021
Chemopreventive and therapeutic effects of nimbolide in cancer: the underlying mechanisms. Toxicology in vitro : an international journal published in association with BIBRA, 2014, Volume: 28, Issue:5 Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Humans; Limonins; Neoplasms	2014
Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development. Oncotarget, 2016, Jul-12, Volume: 7, Issue:28 Topics: Animals; Apoptosis; Azadirachta; Cell Proliferation; Humans; Limonins; Neoplasms; Neovascularization, Pathologic; Phytotherapy; Plant Extracts	2016

Other Studies

2 other study(ies) available for nimbolide and Neoplasms

Article	Year
Nimbolide targets RNF114 to induce the trapping of PARP1 and synthetic lethality in Science advances, 2023, 10-27, Volume: 9, Issue:43 Topics: DNA; Humans; Neoplasms; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Synthetic Lethal Mutations	2023
Modification of cysteine 179 of IkappaBalpha kinase by nimbolide leads to down-regulation of NF-kappaB-regulated cell survival and proliferative proteins and sensitization of tumor cells to chemotherapeutic agents. The Journal of biological chemistry, 2010, Nov-12, Volume: 285, Issue:46 Topics: Amino Acid Substitution; Apoptosis; Azadirachta; Blotting, Western; Caspases; Cell Proliferation; Cell Survival; Cyclin D1; Cysteine; Dose-Response Relationship, Drug; Down-Regulation; HEK293 Cells; HL-60 Cells; Humans; I-kappa B Kinase; Jurkat Cells; K562 Cells; Limonins; Molecular Structure; Neoplasms; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Tumor Necrosis Factor-alpha; U937 Cells; Vascular Endothelial Growth Factor A	2010

Article

Year

Nimbolide targets RNF114 to induce the trapping of PARP1 and synthetic lethality in

Science advances, 2023, 10-27, Volume: 9, Issue:43

Topics: DNA; Humans; Neoplasms; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Synthetic Lethal Mutations

2023

Modification of cysteine 179 of IkappaBalpha kinase by nimbolide leads to down-regulation of NF-kappaB-regulated cell survival and proliferative proteins and sensitization of tumor cells to chemotherapeutic agents.

The Journal of biological chemistry, 2010, Nov-12, Volume: 285, Issue:46

Topics: Amino Acid Substitution; Apoptosis; Azadirachta; Blotting, Western; Caspases; Cell Proliferation; Cell Survival; Cyclin D1; Cysteine; Dose-Response Relationship, Drug; Down-Regulation; HEK293 Cells; HL-60 Cells; Humans; I-kappa B Kinase; Jurkat Cells; K562 Cells; Limonins; Molecular Structure; Neoplasms; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Tumor Necrosis Factor-alpha; U937 Cells; Vascular Endothelial Growth Factor A

2010